SER Randall Moreadith sells $33K worth of shares
Jul 18, 2025, 4:36 AM
0.00%
What does SER do
Serina Therapeutics, based in Alameda, California, is a clinical-stage biotechnology company developing drug candidates for neurological diseases, focusing on SER-252 for Parkinson's Disease. The company went public on November 29, 2018, and employs four people.
Randall Moreadith sold 6,500 shares of SER on 14 July at $5.01 per share, worth a total of $33K. They now own 0 SER shares, or a 100% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.